PomDoctor Ltd. (POM) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

Market Cap

$6.19M

MomentumView details →

1D Return

−4.55%

YTD Return

−84.37%

RSI (14)

40.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

Market Cap

$6.19M

RSI (14)

40.4

MomentumView details →

1D Return

−4.55%

YTD Return

−84.37%

ProfitabilityView details →

Gross Margin

13.07%

Net Margin

−53.16%

EBITDA Margin

−29.48%

ROE (TTM)

46.83%

ROA (TTM)

−197.64%

Asset Turnover

5.20x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+17.71%

EPS CAGR 3Y

+83.20%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

−1.00x

Current Ratio

0.48x

Quick Ratio

0.44x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for POM.

Similar companies

Cellyan Biotechnology Co., LtdHKPD Bio Green Med Solution, Inc.BGMS AIxCrypto Holdings, Inc.AIXC Hoth Therapeutics, Inc.RKTO Bio Green Med Solution, Inc.BGMSP Neuphoria Therapeutics Inc.NEUP Find similar companies →

Latest newsMore news →

No recent news for POM.